Literature DB >> 1026541

A profile for trimipramine.

M Valentine.   

Abstract

A series of sixty-one patients with depressive symptoms were treated with trimipramine in single nightly dosages. Analysis of the data indicated that a favourable outcome was likely to be associated with the following features: absence of gastro-intestinal complaints; absence of hypochondriasis; a level of anxiety not more than the average for psychiatric patients; absence of situational palpitation; possession of a stable work record; and possession of a family history positive for psychiatric disorder. These features are not claimed to be specific to treatment with trimipramine. Age, sex, out-patient/in-patient status and the over-all degree of depression were not found to be relevant. Trimipramine was associated with a favourable outcome in 64% of all cases treated, and in 73% of primarily depressive conditions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1026541     DOI: 10.1177/030006057600400208

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  2 in total

Review 1.  A review of trimipramine. 30 years of clinical use.

Authors:  Y D Lapierre
Journal:  Drugs       Date:  1989       Impact factor: 9.546

2.  Drug use evaluation: A two-year retrospective review of the effectiveness and tolerability of agomelatine versus mirtazapine in patients with depressive disorder.

Authors:  Shek Ming Leung
Journal:  Brain Behav       Date:  2021-08-01       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.